Evidence map›Paper›PMID 39551608›Full record

Observational studyOpen heart2024

Composition of cardiac troponin release differs after marathon running and myocardial infarction.

K E Juhani Airaksinen, Tuomas Paana, Tuija Vasankari, Selma Salonen, Tuulia Tuominen, Anna Linko-Parvinen, Hanna-Mari Pallari, Tapio Hellman, Konsta Teppo, Olli J Heinonen and 2 more

Registry-linked trialAbstract readComparative StudyObservational Study
In one paragraph

Observational study in Open heart, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06000930 (Cardiac Troponin Fragmentation After Heavy Physical Exercise The MaraCat2 Study), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06000930 unknown statusnot on this map

Cardiac Troponin Fragmentation After Heavy Physical Exercise The MaraCat2 Study

TypeobservationalSponsorUniversity of TurkuRan2023 to 2024Enrolled170ConditionsMyocardial Infarction, Myocardial InjuryArmsTroponin fragmentation
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Handling persistent cardiac troponin elevation in asymptomatic athletes: The role of macrocomplexes.American heart journal plus : cardiology research and practice · 2026
    Article
  2. Observational
  3. Observational
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

K E Juhani AiraksinenUniversity of Turku, Turku, Finland juhani.airaksinen@tyks.fi.ORCID 0000-0002-0193-568X
Tuomas PaanaHeart Centre, Turku University Hospital, Turku, Finland.
Tuija VasankariUniversity of Turku, Turku, Finland.
Selma SalonenBiotechnology Unit, Department of Life technologies, University of Turku, Turku, Finland.ORCID 0009-0000-7941-5951
Tuulia TuominenBiotechnology Unit, Department of Life technologies, University of Turku, Turku, Finland.ORCID 0009-0004-6239-4348
Anna Linko-ParvinenClinical Chemistry, TYKS Turku University Hospital, Turku, Finland.
Hanna-Mari PallariClinical Chemistry, TYKS Turku University Hospital, Turku, Finland.
Tapio HellmanUniversity of Turku, Turku, Finland.
Konsta TeppoUniversity of Turku, Turku, Finland.
Olli J HeinonenPaavo Nurmi Centre & Department of Physical Activity and Health, University of Turku, Turku, Finland.
Samuli JaakkolaUniversity of Turku, Turku, Finland.ORCID 0000-0001-5944-6814
Saara WittfoothBiotechnology Unit, Department of Life technologies, University of Turku, Turku, Finland.ORCID 0000-0002-7886-3477

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesElevations of cardiac troponin T (cTnT) levels are common after strenuous exercise. We assessed whether the composition of cTnT release after marathon race differs from that of acute myocardial infarction (MI).

methodsTroponin composition was analysed in plasma samples taken from 45 runners after marathon race and from 84 patients with type 1 MI. The concentration of long cTnT (intact and mildly fragmented cTnT) was measured with a novel upconversion luminescence immunoassay, total cTnT with a commercial high-sensitivity cTnT assay, and the ratio of long to total cTnT (troponin ratio) was determined as a measure of troponin fragmentation.

resultsTotal cTnT exceeded the upper reference limit (>14 ng/L) in 37 (82%) runners. Troponin ratio was lower in runners ((IQR) 0.17 (0.11-0.24) vs 0.62 (0.29-0.96), p<0.001). With increasing troponin release the troponin ratio decreased (r=-0.497, p<0.001) in marathon runners and the concentration of long cTnT remained in all runners below 8.4 ng/L. In contrast to marathon runners, troponin ratio increased (r=0.565, p<0.001) with the increase of cTnT release in patients with MI. The median total and long cTnT concentrations were lower in marathon runners than in patients with MI (25 ng/L vs 835 ng/L and 4.1 vs 385 ng/L, p<0.001 for both).

conclusionIn contrast to type 1 MI, only a small fraction of circulating cTnT exists as intact cTnT or long molecular forms after strenuous exercise and the difference in troponin composition is more pronounced in runners with higher troponin release. TRIAL REGISTRATION NUMBER: NCT06000930.

Indexed as

BiomarkersMarathon RunningMyocardial InfarctionTroponin TAdultAgedFemaleHumansMaleMiddle AgedRunningTime FactorsBiomarkersTroponin TBiomarkersChest PainMyocardial Infarction

Identifiers

PMID39551608
PMCPMC11574483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.